Barclays Upgrades Element Solutions to Overweight, Lowers Price Target to $22
Barclays analyst Michael Leithead upgrades Element Solutions (NYSE:ESI) from Equal-Weight to Overweight and lowers the price target from $24 to $22.
Morgan Stanley Downgrades New Relic to Equal-Weight, Announces $64 Price Target
Morgan Stanley analyst Sanjit Singh downgrades New Relic (NYSE:NEWR) from Overweight to Equal-Weight and announces $64 price target.
Wolfe Research Downgrades Moelis & Co to Underperform, Announces $42 Price Target
Wolfe Research analyst Steven Chubak downgrades Moelis & Co (NYSE:MC) from Peer Perform to Underperform and announces $42 price target.
BMO Capital Downgrades Kura Sushi USA to Market Perform, Announces $80 Price Target
BMO Capital analyst Andrew Strelzik downgrades Kura Sushi USA (NASDAQ:KRUS) from Outperform to Market Perform and announces $80 price target.
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Lowers Price Target to $54
HC Wainwright & Co. analyst Robert Burns maintains Nurix Therapeutics (NASDAQ:NRIX) with a Buy and lowers the price target from $60 to $54.
HC Wainwright & Co. Maintains Buy on Kiora Pharmaceuticals, Lowers Price Target to $2.5
HC Wainwright & Co. analyst Yi Chen maintains Kiora Pharmaceuticals (NASDAQ:KPRX) with a Buy and lowers the price target from $3 to $2.5.
Read Why Goldman Sachs Turns Bullish On This Toy Maker
Goldman Sachs analyst Michael Ng upgraded Mattel Inc (NASDAQ:MAT) to Buy from Neutral with a price target of $31, up from $30, implying…
HC Wainwright & Co. Maintains Buy on BioNTech, Lowers Price Target to $283
HC Wainwright & Co. analyst Robert Burns maintains BioNTech (NASDAQ:BNTX) with a Buy and lowers the price target from $298 to $283.
HC Wainwright & Co. Maintains Buy on Endeavour Silver, Lowers Price Target to $8.25
HC Wainwright & Co. analyst Heiko Ihle maintains Endeavour Silver (NYSE:EXK) with a Buy and lowers the price target from $8.5 to $8.25.
Goldman Sachs Downgrades Occidental Petroleum to Neutral, Announces $70 Price Target
Goldman Sachs analyst Neil Mehta downgrades Occidental Petroleum (NYSE:OXY) from Buy to Neutral and announces $70 price target.